- Conditions
- Urologic Diseases, Hypospadias, Undescended Testes, Chordee, Hydrocele, Orchiectomy
- Interventions
- Exparel 133 miligrams per 10 milliliter injection, Bupivacaine Hydrochloride
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 6 Years and older
- Enrollment
- 104 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Source: ClinicalTrials.gov public record
Updated Dec 25, 2023 · Synced May 22, 2026, 1:16 AM EDT